Celltrion received marketing authorization of 'Remsima' in the Japanese MHLW
On July 4, Celltrion announced that they received marketing authorization of 'Remsima' in the Japanese MHLW( Ministry of Health, labour and Welfare).
According to Celltrion, they applied for marketing approval of Remsima in PMDA (Pharmaceuticals and Medical Devices Agency, Japan) on last Septemb...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
